Fox-Fordyce Disease
To view the entire topic, please log in or purchase a subscription.
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
A rare chronic pruritic skin condition involving apocrine glands. Named for the physicians who first described it (1); also known as apocrine duct occlusion or apocrine miliaria; caused by destruction of follicular infundibulum with keratin debris
Epidemiology
Incidence
A rare condition without geographic, ethnic, or racial predilection. Approximately 90% of patients are women between the ages of 13 and 35 years. 10 times more common to occur in women than men. Incidence of the disorder is unknown.
Etiology and Pathophysiology
- A defect in the follicular infundibulum causes follicular dilation with keratin plugging. This results in apocrine duct obstruction, rupture, and inflammation (2,3), which causes extravasation of the apocrine secretions.
- Although blockage of the apocrine duct seems important in disease development, experimentally plugging the duct has not clinically reproduced disease manifestations.
- Unknown/possibly endocrine related
Genetics
- The genetics of Fox-Fordyce are unknown but likely play in role. There have been reports of the disease occurring in identical male twins, one set of siblings, in a father and daughter, in two patients with Turner syndrome, and in one patient with a small deletion on chromosome 21.
- Hormones
- The role of hormones in Fox-Fordyce has been largely debated (1); disease onset after puberty and improvement with pregnancy and estrogens lends support to a hormonal influence.
- However, hormonal studies in one patient with Fox-Fordyce did not reveal any abnormalities.
Commonly Associated Conditions
- Possibly related to hyperhidrosis
- Hidradenitis suppurativa (rare)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
A rare chronic pruritic skin condition involving apocrine glands. Named for the physicians who first described it (1); also known as apocrine duct occlusion or apocrine miliaria; caused by destruction of follicular infundibulum with keratin debris
Epidemiology
Incidence
A rare condition without geographic, ethnic, or racial predilection. Approximately 90% of patients are women between the ages of 13 and 35 years. 10 times more common to occur in women than men. Incidence of the disorder is unknown.
Etiology and Pathophysiology
- A defect in the follicular infundibulum causes follicular dilation with keratin plugging. This results in apocrine duct obstruction, rupture, and inflammation (2,3), which causes extravasation of the apocrine secretions.
- Although blockage of the apocrine duct seems important in disease development, experimentally plugging the duct has not clinically reproduced disease manifestations.
- Unknown/possibly endocrine related
Genetics
- The genetics of Fox-Fordyce are unknown but likely play in role. There have been reports of the disease occurring in identical male twins, one set of siblings, in a father and daughter, in two patients with Turner syndrome, and in one patient with a small deletion on chromosome 21.
- Hormones
- The role of hormones in Fox-Fordyce has been largely debated (1); disease onset after puberty and improvement with pregnancy and estrogens lends support to a hormonal influence.
- However, hormonal studies in one patient with Fox-Fordyce did not reveal any abnormalities.
Commonly Associated Conditions
- Possibly related to hyperhidrosis
- Hidradenitis suppurativa (rare)
There's more to see -- the rest of this topic is available only to subscribers.